ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,257.30
0.31%
Dow Jones
38,716.65
0.01%
Gold vs US Dollar
2,350.935
0.95%
Brent Oil
77.245
0.18%
Bitcoin
71,204.60
0.82%
Pepperstone
Advertisement
Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ

  6. BioLineRx Ltd (BLRX) Share Price

BLRX BioLineRx Ltd

0.7036
0.00485 (0.69%)
Last Updated: 16:04:50
Delayed by 15 minutes
 Name  Symbol  Market  Type  ISIN  Description 
 BioLineRx Ltd NASDAQ:BLRX NASDAQ Depository Receipt  ADS
     Change  % Chg  Cur  Bid  Offer  High  Low  Open  Volume  Chg Time
Upgrade Icon
 		 RN  NRN 
   0.00485 0.69 0.7036 0.70 0.7089 0.7127 0.6902 0.7 27,289 15:04:50   
 Sector  Turnover  Profit  EPS - Basic  PE ratio  Mkt Cap 
 Pharmaceutical Preparations 4.8M -60.61M - N/A 
 Type  Size  Price  Time  Units 
  100 0.7036 15:04:50 USD
 
Pre-Market and After-Hours
Recent News
DateTimeSource
HeadlineMore BLRX News
30/05/202412:16EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
28/05/202412:31IHMARKETNEWSU.S. Futures Present Mixed Pre-Market Performance, Oil Prices Surge
28/05/202412:11EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
24/05/202412:05EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
17/05/202422:07EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
06/05/202412:14EDGAR2Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]
17/04/202412:00PRNUSBioLineRx Announces Poster Presentation on Apheresis Center Efficiency and CXCR4 Antagonists including APHEXDA® (motixafortide) in Patients with Multiple Myeloma at the ASFA 2024 Annual Meeting
Period
Draw mode
Data Downloads for BLRX

Export historical price information open, high, low, close, volume (OHLCV) to Excel

Intraday price data (2 weeks, 1 minute bars)


Loading Follow Feed...

Latest BioLineRx Ltd Articles